Oral apixaban for the treatment of venous thromboembolism in cancer patients: Results from the AMPLIFY trial

Journal of Thrombosis and Haemostasis

Volumn 13, Issue 12, 2015, Pages 2187-2191

  Agnelli, G ^a   Buller, H R ^b   Cohen, A ^c   Gallus, A S ^d   Lee, T C ^e   Pak, R ^e   Raskob, G E ^f   Weitz, J I ^g   Yamabe, T ^e  

^a UNIVERSITY OF PERUGIA   (Italy)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d FLINDERS MEDICAL CENTRE   (Australia)

^e PFIZER INC   (United States)

^f UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^g MCMASTER UNIVERSITY   (Canada)

Author keywords

Anticoagulants; Apixaban; Cancer; Enoxaparin; Venous thromboembolism

Indexed keywords

APIXABAN; ENOXAPARIN; WARFARIN; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A INHIBITOR; PYRAZOLE DERIVATIVE; PYRIDONE DERIVATIVE;

AGED; ARTICLE; BLEEDING; CANCER PATIENT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM; BLOOD; CHEMICALLY INDUCED; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; COMPLICATION; MIDDLE AGED; NEOPLASM; ODDS RATIO; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME;

AGED; ANTICOAGULANTS; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; ENOXAPARIN; FACTOR XA INHIBITORS; FEMALE; HEMORRHAGE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASMS; ODDS RATIO; PYRAZOLES; PYRIDONES; RECURRENCE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; WARFARIN;

EID: 84958756732     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.13153     Document Type: Article

References (8)

1. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000; 160: 809-15.
2. Prandoni P, Lensing AWA, Piccioli A, Bernardi E, Simioni P, Girolami B, Marchiori A, Sabbion P, Prins MH, Noventa F, Girolami A. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 2002; 100: 3484-8.
3. Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Masiukiewicz U, Pak R, Thompson J, Raskob GE, Weitz JI; AMPLIFY Investigators. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 2013; 369: 799-808.
4. Raskob GE, Buller H, Angchaisuksiri P, Oh D, Boda Z, Lyons RL, Weitz JI, Zhang G, Lanz HJ, Mercuri M. Edoxaban for long-term treatment of venous thromboembolism in cancer patients. American Society of Hematology; New Orleans, LA; 2013 Oral session 332. Blood 2013; 122: 211.
5. Lee AYY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, Rickles FR, Julian JA, Haley S, Kovacs MJ, Gent M; Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003; 349: 146-53.
6. Lee YY, Kamphuisen PW, Meyer G, Bauersachs R, Mette S, Mikala J, Jarner F, Alok A, Khorana MD, on behalf of the CATCH Investigators. Randomized trial of long-term tinzaparin, a low molecular weight heparin (LMWH), versus warfarin for treatment of acute venous thromboembolism (VTE) in cancer patients - the CATCH Study. Abstract LBA-2. American Society of Hematology 56th Annual Meeting; December 2014; San Francisco, CA.
7. Konstantinides S, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, et al.; Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014; 35: 3033-69.
8. Kleinjan A, Aggarwal A, van de Geer A, Faselis C, Büller HR, Di Nisio M, Rickles FR, Kamphuisen PW. A worldwide survey to assess the current approach to the treatment of patients with cancer and venous thromboembolism. Thromb Haemost 2013; 110: 959-65.